146 related articles for article (PubMed ID: 38247091)
1. [History of the Japanese Society of Medical Oncology].
Ishioka C; Minami H; Ohe Y; Tamura K; Saijo N
Gan To Kagaku Ryoho; 2024 Jan; 51(1):45-52. PubMed ID: 38247091
[TBL] [Abstract][Full Text] [Related]
2. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
[TBL] [Abstract][Full Text] [Related]
3. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
Mishima S; Naito Y; Akagi K; Hayashi N; Hirasawa A; Hishiki T; Igarashi A; Ikeda M; Kadowaki S; Kajiyama H; Kato M; Kenmotsu H; Kodera Y; Komine K; Koyama T; Maeda O; Miyachi M; Nishihara H; Nishiyama H; Ohga S; Okamoto W; Oki E; Ono S; Sanada M; Sekine I; Takano T; Tao K; Terashima K; Tsuchihara K; Yatabe Y; Yoshino T; Baba E
Int J Clin Oncol; 2023 Oct; 28(10):1237-1258. PubMed ID: 37599324
[TBL] [Abstract][Full Text] [Related]
4. Japan society of clinical oncology/Japanese society of medical oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors, cooperated by the Japanese society of pediatric hematology/oncology.
Naito Y; Mishima S; Akagi K; Igarashi A; Ikeda M; Okano S; Kato S; Takano T; Tsuchihara K; Terashima K; Nishihara H; Nishiyama H; Hiyama E; Hirasawa A; Hosoi H; Maeda O; Yatabe Y; Okamoto W; Ono S; Kajiyama H; Nagashima F; Hatanaka Y; Miyachi M; Kodera Y; Yoshino T; Taniguchi H
Int J Clin Oncol; 2020 Mar; 25(3):403-417. PubMed ID: 31974683
[TBL] [Abstract][Full Text] [Related]
5. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.
Mishima S; Naito Y; Akagi K; Hayashi N; Hirasawa A; Hishiki T; Igarashi A; Ikeda M; Kadowaki S; Kajiyama H; Kato M; Kenmotsu H; Kodera Y; Komine K; Koyama T; Maeda O; Miyachi M; Nishihara H; Nishiyama H; Ohga S; Okamoto W; Oki E; Ono S; Sanada M; Sekine I; Takano T; Tao K; Terashima K; Tsuchihara K; Yatabe Y; Yoshino T; Baba E
Int J Clin Oncol; 2023 Aug; 28(8):941-955. PubMed ID: 37300720
[TBL] [Abstract][Full Text] [Related]
6. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.
Naito Y; Mishima S; Akagi K; Hayashi N; Hirasawa A; Hishiki T; Igarashi A; Ikeda M; Kadowaki S; Kajiyama H; Kato M; Kenmotsu H; Kodera Y; Komine K; Koyama T; Maeda O; Miyachi M; Nishihara H; Nishiyama H; Ohga S; Okamoto W; Oki E; Ono S; Sanada M; Sekine I; Takano T; Tao K; Terashima K; Tsuchihara K; Yatabe Y; Yoshino T; Baba E
Int J Clin Oncol; 2023 Jul; 28(7):827-840. PubMed ID: 37212982
[TBL] [Abstract][Full Text] [Related]
7. Report from the 1st Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2006: 'A step towards better collaboration between urologists and medical oncologists'.
Akaza H
Int J Urol; 2007 May; 14(5):375-83. PubMed ID: 17511716
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis.
Ozaki A; Saito H; Onoue Y; Sawano T; Shimada Y; Somekawa Y; Tsuji A; Tanimoto T
BMJ Open; 2019 Sep; 9(9):e028805. PubMed ID: 31494604
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a research policy for supportive and palliative care in Japan.
Zenda S; Uchitomi Y; Morita T; Yamaguchi T; Inoue A
Jpn J Clin Oncol; 2021 Apr; 51(4):538-543. PubMed ID: 33561254
[TBL] [Abstract][Full Text] [Related]
10. A nationwide, cross-sectional, web-based survey on healthcare providers' knowledge about, attitudes toward, and perceived barriers to adherence to clinical practice guidelines for anticancer drug therapy for older patients with cancer in Japan.
Matsuoka A; Shimazu T; Takahashi M; Nagashima F; Nishiyama H; Fujimori M; Ando Y
J Geriatr Oncol; 2023 Jan; 14(1):101399. PubMed ID: 36357276
[TBL] [Abstract][Full Text] [Related]
11. Practical management of older adults with cancer: geriatric oncology in Japan.
Mizutani T
Jpn J Clin Oncol; 2022 Oct; 52(10):1073-1081. PubMed ID: 35863011
[TBL] [Abstract][Full Text] [Related]
12. Report from the second Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2007: 'diagnosis and treatment of urological malignant tumors: how can we promote subspecialists?'.
Saijo N; Miki T; Kubota Y; Naito S; Akaza H; Takahashi S; Minami H
Int J Urol; 2008 May; 15(5):389-93. PubMed ID: 18452453
[TBL] [Abstract][Full Text] [Related]
13. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
[TBL] [Abstract][Full Text] [Related]
14. [Training Advanced Cancer Professionals for Genome and Generation].
Koizumi M
Gan To Kagaku Ryoho; 2022 Jun; 49(6):624-631. PubMed ID: 35799385
[TBL] [Abstract][Full Text] [Related]
15. Current state and future prospects for psychosomatic medicine in Japan.
Murakami M; Nakai Y
Biopsychosoc Med; 2017; 11():1. PubMed ID: 28105067
[TBL] [Abstract][Full Text] [Related]
16. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
17. Meeting report: Current cancer perspectives from the 9
Nurwidya F; Takahashi F; Takahashi K
Thorac Cancer; 2012 Feb; 3(1):94-97. PubMed ID: 28920256
[TBL] [Abstract][Full Text] [Related]
18. JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
Yoshino T; Pentheroudakis G; Mishima S; Overman MJ; Yeh KH; Baba E; Naito Y; Calvo F; Saxena A; Chen LT; Takeda M; Cervantes A; Taniguchi H; Yoshida K; Kodera Y; Kitagawa Y; Tabernero J; Burris H; Douillard JY
Ann Oncol; 2020 Jul; 31(7):861-872. PubMed ID: 32272210
[TBL] [Abstract][Full Text] [Related]
19. Japanese Society of Medical Oncology Clinical Guidelines: Molecular Testing for Colorectal Cancer Treatment, Third Edition.
Yamazaki K; Taniguchi H; Yoshino T; Akagi K; Ishida H; Ebi H; Nakatani K; Muro K; Yatabe Y; Yamaguchi K; Tsuchihara K
Cancer Sci; 2018 Jun; 109(6):2074-2079. PubMed ID: 29873882
[TBL] [Abstract][Full Text] [Related]
20. Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 2.
Tozawa A; Kimura F; Takai Y; Nakajima T; Ushijima K; Kobayashi H; Satoh T; Harada M; Sugimoto K; Saji S; Shimizu C; Akiyama K; Bando H; Kuwahara A; Furui T; Okada H; Kawai K; Shinohara N; Nagao K; Kitajima M; Suenobu S; Soejima T; Miyachi M; Miyoshi Y; Yoneda A; Horie A; Ishida Y; Usui N; Kanda Y; Fujii N; Endo M; Nakayama R; Hoshi M; Yonemoto T; Kiyotani C; Okita N; Baba E; Muto M; Kikuchi I; Morishige KI; Tsugawa K; Nishiyama H; Hosoi H; Tanimoto M; Kawai A; Sugiyama K; Boku N; Yonemura M; Hayashi N; Aoki D; Suzuki N; Osuga Y
Int J Clin Oncol; 2022 Feb; 27(2):281-300. PubMed ID: 35022887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
